ICAV 11th International Symposium

Attention: open in a new window. PDFPrint option in slimbox / lytebox? (info)E-mail

Infectious Diseases: Global Public-Health Challenges of the Next Decade

In honour of the late Donald E. Low, M.D., FRCPC

November 17, 2014 - Satellite Workshop


Workshop Description

Schedule and Speakers

November 18 – 20, 2014
The Schulich School of Business
York University, Toronto, Canada


It has been over ten years since SARS arrived in Toronto. In the interim, the world has experienced the 2009 H1N1 influenza pandemic and a resurgence of polio while outbreaks of MDR-TB, MERS, and Ebola still threaten and dengue is spreading around the world. Inadequate surveillance tools, the lack of diagnostic tests and therapeutic agents plus the vastly increased ease of global transmission, the rise of antibiotic resistance, and public policy deficits are major challenges to adequate preparation. What can we do over the next ten years to be better prepared?

The Symposium will include sessions on the infectious disease challenges facing different regions of the globe. Among the diseases that will be examined are those caused by the: H7N9 influenza virus, MERS coronavirus, Ebola, dengue and chikungunya viruses as well as drug-resistant tuberculosis. New targets for drug development, new approaches to therapies for those infected and the health policy obstacles to implementation, will be addressed.

Key objectives of the Symposium include:

  • Advance research and development of new anti-infective therapies by building collaborations between scientists, health care providers, public health experts and industry partners
  • Introduce students and postdoctoral fellows to the exciting opportunities to work on problems of global importance, and promote international exchanges
  • Facilitate dialog between the public health and research communities, leading to improved policies and practices to better prepare for and confront the challenge of infectious diseases
  • Accelerate the launch of two specific technologies; the first being a novel anti-infective to combat multi-drug resistant tuberculosis, and second being the use of therapeutic antibodies to treat persons critically ill from infectious diseases.

Opportunities will be provided for young investigators to present their work along with invited keynote speakers. The young investigators will be selected on the basis of the quality of their submitted Abstracts. Panel discussions and Poster sessions will also be held to provide informal settings for interaction between and among Delegates and Speakers.